Combining clinically studied ingredients with enhanced bioavailability, at Natural Products Expo West, Asha Ramesh, Sabinsa’s CEO – Americas, highlights the growing importance of safety data, regulatory compliance, and full documentation as brands navigate increasing scrutiny in supplement development.
Women’s health, cognition, GLP-1 support, longevity, and clean-label functional foods are among the key categories influencing demand for clinically substantiated nutraceutical ingredients, notes Asha Ramesh, Sabinsa’s CEO – Americas, from the Expo West floor.
Sponsored
Asha Ramesh, CEO - Americas, dives into Sabinsa's exploration of specific turmeric-derived compounds to support diverse aspects of human health.
Sponsored
Discover how Sabinsa is moving beyond generic supplements to provide clinically-studied ingredients that address the entire spectrum of active nutrition, from training and recovery to metabolic and gut health.
